GLP-2 GLP-1/GIP Dual Receptor Agonist

Description

Overview A dual-pathway incretin peptide supplied as lyophilized powder in sealed vial format. Available at 10mg, 20mg, 40mg and 60mg, the widest strength range in the incretin catalog. Supplied for controlled in vitro work by qualified laboratory personnel.

Research Background & Mechanistic Focus Studied for simultaneous engagement of two distinct incretin receptors, GLP-1 and GIP, from a single molecule. The question driving most dual agonist work is whether combined receptor engagement produces signaling behavior that differs from two separate single-pathway agonists run alongside each other. Laboratory use typically involves parallel receptor occupancy assays, comparative cAMP response profiling across both receptor populations, and selectivity ratio characterization. It is most often run directly against the single-pathway arm as comparator.

Structural Information Classification: Dual-pathway incretin research peptide Form: Lyophilized vial presentation Catalog Strengths: 10mg, 20mg, 40mg, 60mg  

Research Applications Used in controlled laboratory settings for receptor-signaling models, comparative pathway analysis, presentation or stability work where applicable, and other non-clinical analytical workflows consistent with authorized research use.  

Specifications Research-grade material supplied in lyophilized vial presentation at selected catalog variants. Intended for controlled laboratory handling and analytical preparation only.  

Handling & Use Conditions Allow the vial to equilibrate before opening. Reconstitute only under controlled laboratory conditions using appropriate technique. Avoid vigorous agitation, repeated freeze-thaw exposure, and unnecessary environmental exposure during handling.  

Storage & Stability Store refrigerated or frozen according to laboratory protocol, protected from light and repeated freeze-thaw cycling. Reconstituted material should be stored only under controlled conditions appropriate for short-term analytical use.  

Sourcing Statement RawBiotix research compounds are sourced through U.S.-based supply and verified through independent analytical testing. Minimum 98% purity. Certificates of Analysis available upon request.  

Disclaimer For laboratory research use only. Not for human consumption, therapeutic, or diagnostic purposes.